microRNA-301a regulation of a T-helper 17 immune response controls autoimmune demyelination
Mycko, Marcin P., Cichalewska, Maria, Machlanska, Agnieszka, Cwiklinska, Hanna, Mariasiewicz, Magdalena, Selmaj, Krzysztof W.
Published in Proceedings of the National Academy of Sciences - PNAS (15.05.2012)
Published in Proceedings of the National Academy of Sciences - PNAS (15.05.2012)
Get full text
Journal Article
Alemtuzumab for patients with relapsing multiple sclerosis after disease-modifying therapy: a randomised controlled phase 3 trial
Coles, Alasdair J, Dr, Twyman, Cary L, MD, Arnold, Douglas L, Prof, Cohen, Jeffrey A, Prof, Confavreux, Christian, Prof, Fox, Edward J, MD, Hartung, Hans-Peter, Prof, Havrdova, Eva, Prof, Selmaj, Krzysztof W, Prof, Weiner, Howard L, Prof, Miller, Tamara, MD, Fisher, Elizabeth, PhD, Sandbrink, Rupert, MD, Lake, Stephen L, ScD, Margolin, David H, MD, Oyuela, Pedro, MD, Panzara, Michael A, MD, Compston, D Alastair S, Prof
Published in The Lancet (British edition) (24.11.2012)
Published in The Lancet (British edition) (24.11.2012)
Get full text
Journal Article
Alemtuzumab versus interferon beta 1a as first-line treatment for patients with relapsing-remitting multiple sclerosis: a randomised controlled phase 3 trial
Cohen, Jeffrey A, Prof, Coles, Alasdair J, PhD, Arnold, Douglas L, Prof, Confavreux, Christian, Prof, Fox, Edward J, MD, Hartung, Hans-Peter, Prof, Havrdova, Eva, Prof, Selmaj, Krzysztof W, Prof, Weiner, Howard L, Prof, Fisher, Elizabeth, PhD, Brinar, Vesna V, MD, Giovannoni, Gavin, Prof, Stojanovic, Miroslav, MD, Ertik, Bella I, MD, Lake, Stephen L, ScD, Margolin, David H, MD, Panzara, Michael A, MD, Compston, D Alastair S, Prof
Published in The Lancet (British edition) (24.11.2012)
Published in The Lancet (British edition) (24.11.2012)
Get full text
Journal Article
Safety and efficacy of the selective sphingosine 1-phosphate receptor modulator ozanimod in relapsing multiple sclerosis (RADIANCE): a randomised, placebo-controlled, phase 2 trial
Cohen, Jeffrey A, Dr, Arnold, Douglas L, MD, Comi, Giancarlo, MD, Bar-Or, Amit, MD, Gujrathi, Sheila, MD, Hartung, Jeffrey P, PhD, Cravets, Matt, MA, Olson, Allan, MD, Frohna, Paul A, MD, Selmaj, Krzysztof W, MD
Published in Lancet neurology (01.04.2016)
Published in Lancet neurology (01.04.2016)
Get full text
Journal Article
Impact of Diminished Expression of circRNA on Multiple Sclerosis Pathomechanisms
Mycko, Marcin P., Zurawska, Anna E., Selmaj, Igor, Selmaj, Krzysztof W.
Published in Frontiers in immunology (03.06.2022)
Published in Frontiers in immunology (03.06.2022)
Get full text
Journal Article
Alemtuzumab versus interferon beta-1a in early relapsing-remitting multiple sclerosis: post-hoc and subset analyses of clinical efficacy outcomes
Coles, Alasdair J, MD, Fox, Edward, MD, Vladic, Anton, MD, Gazda, Suzanne K, MD, Brinar, Vesna, MD, Selmaj, Krzysztof W, MD, Bass, Ann Doan-Do, DO, Wynn, Daniel R, MD, Margolin, David H, MD, Lake, Stephen L, ScD, Moran, Susan, MD, Palmer, Jeffrey, MS, Smith, M Shelton, PhD, Compston, D Alastair S, MD
Published in Lancet neurology (01.04.2011)
Published in Lancet neurology (01.04.2011)
Get full text
Journal Article
Efficacy and safety of alemtuzumab over 6 years: final results of the 4-year CARE-MS extension trial
Coles, Alasdair J., Arnold, Douglas L., Bass, Ann D., Boster, Aaron L., Compston, D. Alastair S., Fernández, Óscar, Havrdová, Eva Kubala, Nakamura, Kunio, Traboulsee, Anthony, Ziemssen, Tjalf, Jacobs, Alan, Margolin, David H., Huang, Xiaobi, Daizadeh, Nadia, Chirieac, Madalina C., Selmaj, Krzysztof W.
Published in Therapeutic advances in neurological disorders (2021)
Published in Therapeutic advances in neurological disorders (2021)
Get full text
Journal Article
The role of exosomes in CNS inflammation and their involvement in multiple sclerosis
Selmaj, Igor, Mycko, Marcin P, Raine, Cedric S, Selmaj, Krzysztof W
Published in Journal of neuroimmunology (15.05.2017)
Published in Journal of neuroimmunology (15.05.2017)
Get full text
Journal Article
Circular RNAs as a novel layer of regulatory mechanism in multiple sclerosis
Zurawska, Anna, Mycko, Marcin P., Selmaj, Krzysztof W.
Published in Journal of neuroimmunology (15.09.2019)
Published in Journal of neuroimmunology (15.09.2019)
Get full text
Journal Article
Safety and efficacy of ozanimod versus interferon beta-1a in relapsing multiple sclerosis (SUNBEAM): a multicentre, randomised, minimum 12-month, phase 3 trial
Comi, Giancarlo, Kappos, Ludwig, Selmaj, Krzysztof W, Bar-Or, Amit, Arnold, Douglas L, Steinman, Lawrence, Hartung, Hans-Peter, Montalban, Xavier, Kubala Havrdová, Eva, Cree, Bruce A C, Sheffield, James K, Minton, Neil, Raghupathi, Kartik, Ding, Ning, Cohen, Jeffrey A
Published in Lancet neurology (01.11.2019)
Published in Lancet neurology (01.11.2019)
Get full text
Journal Article
Safety and efficacy of ozanimod versus interferon beta-1a in relapsing multiple sclerosis (RADIANCE): a multicentre, randomised, 24-month, phase 3 trial
Cohen, Jeffrey A, Comi, Giancarlo, Selmaj, Krzysztof W, Bar-Or, Amit, Arnold, Douglas L, Steinman, Lawrence, Hartung, Hans-Peter, Montalban, Xavier, Kubala Havrdová, Eva, Cree, Bruce A C, Sheffield, James K, Minton, Neil, Raghupathi, Kartik, Huang, Vivian, Kappos, Ludwig
Published in Lancet neurology (01.11.2019)
Published in Lancet neurology (01.11.2019)
Get full text
Journal Article
A heat shock protein gene (Hsp70.1) is critically involved in the generation of the immune response to myelin antigen
Mycko, Marcin P., Cwiklinska, Hanna, Walczak, Agata, Libert, Claude, Raine, Cedric S., Selmaj, Krzysztof W.
Published in European journal of immunology (01.07.2008)
Published in European journal of immunology (01.07.2008)
Get full text
Journal Article
Fluid phase biomarkers in multiple sclerosis
Selmaj, Krzysztof W, Mycko, Marcin P, Furlan, Roberto, Rejdak, Konrad
Published in Current opinion in neurology (01.06.2022)
Published in Current opinion in neurology (01.06.2022)
Get more information
Journal Article
Multiple sclerosis: Serum-derived exosomes express myelin proteins
Galazka, Grazyna, Mycko, Marcin P, Selmaj, Igor, Raine, Cedric S, Selmaj, Krzysztof W
Published in Multiple sclerosis (01.04.2018)
Published in Multiple sclerosis (01.04.2018)
Get more information
Journal Article
Alemtuzumab CARE-MS II 5-year follow-up: Efficacy and safety findings
Coles, Alasdair J, Cohen, Jeffrey A, Fox, Edward J, Giovannoni, Gavin, Hartung, Hans-Peter, Havrdova, Eva, Schippling, Sven, Selmaj, Krzysztof W, Traboulsee, Anthony, Compston, D Alastair S, Margolin, David H, Thangavelu, Karthinathan, Chirieac, Madalina C, Jody, Darlene, Xenopoulos, Panos, Hogan, Richard J, Panzara, Michael A, Arnold, Douglas L
Published in Neurology (12.09.2017)
Published in Neurology (12.09.2017)
Get more information
Journal Article
Alemtuzumab CARE-MS I 5-year follow-up: Durable efficacy in the absence of continuous MS therapy
Havrdova, Eva, Arnold, Douglas L, Cohen, Jeffrey A, Hartung, Hans-Peter, Fox, Edward J, Giovannoni, Gavin, Schippling, Sven, Selmaj, Krzysztof W, Traboulsee, Anthony, Compston, D Alastair S, Margolin, David H, Thangavelu, Karthinathan, Rodriguez, Claudio E, Jody, Darlene, Hogan, Richard J, Xenopoulos, Panos, Panzara, Michael A, Coles, Alasdair J
Published in Neurology (12.09.2017)
Published in Neurology (12.09.2017)
Get more information
Journal Article